| Chembio Diagnostics (CEMI) | |||
|---|---|---|---|
| 6.55 0.24 (3.8%) | 01-25 16:00 | ||
| Open: | 6.25 | Pre. Close: | 6.31 |
| High: | 6.55 | Low: | 6.01 |
| Volume: | 905,234 | Market Cap: | 132M |
| Prices Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 6.559 - 6.585 | 6.585 - 6.61 |
| Low: | 5.948 - 5.976 | 5.976 - 6.002 |
| Close: | 6.503 - 6.549 | 6.549 - 6.593 |
| Stock Technical Analysis | |
|---|---|
| Overall: |   |
| Target: | Six months: 7.70 One year: 8.99 |
| Support: | Support1: 5.37 Support2: 4.62 |
| Resistance: | Resistance1: 6.59 Resistance2: 7.70 |
| Pivot: | 5.64  |
| Moving Averages: | MA(5): 6.23 MA(20): 5.45 MA(100): 5.05 MA(250): 5.95 |
| MACD: | MACD(12,26): 0.25 Signal(12,26,9): 0.11 |
| %K %D: | %K(14,3): 87.86 %D(3): 82.47 |
| RSI: | RSI(14): 66.23 |
| 52-Week: | High: 15.89 Low: 2.25 Change(%): 64.2 |
| Average Vol(K): | 3-Month: 158269 10-Days: 124810 |
| Price, MAs and Bollinger Bands |
|---|
| Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.CEMI has closed below upper band by 5.9%. Bollinger Bands are 35.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
| Stock chart |
|---|
 |
| Financial Analysis | |
|---|---|
| Growth |  |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. | |
| Profitability |  |
| Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs. | |
| Solvency |  |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. | |
| Efficiency |  |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. | |
| Stock Basics & Statistics | |
|---|---|
| Exchange: NASDAQ Capital Market | |
| Sector: Healthcare | |
| Industry: Diagnostics & Research | |
| Shares Out. (M) | 20.18 |
| Shares Float (M) | 17.52 |
| % Held by Insiders | 13.89 |
| % Held by Institutions | 33.75 |
| Shares Short (K) | 3870 |
| Shares Short Prior Month (K) | 4140 |
| Stock Financials | |
|---|---|
| EPS | -1.220 |
| Book Value (p.s.) | 1.680 |
| Profit Margin | -76.55 |
| Operating Margin | -63.26 |
| Return on Assets (ttm) | -18.1 |
| Return on Equity (ttm) | -74.6 |
| Qtrly Rev. Growth | 5.7 |
| Gross Profit (p.s.) | 0.175 |
| Sales Per Share | 1.442 |
| EBITDA (p.s.) | -0.811 |
| Qtrly Earnings Growth | |
| Operating Cash Flow (M) | -16.80 |
| Levered Free Cash Flow (M) | -11.51 |
| Stock Valuation | |
|---|---|
| PE Ratio | -5.37 |
| PEG Ratio | |
| Price to Book value | 3.90 |
| Price to Sales | 4.54 |
| Price to Cash Flow | -7.87 |
| Stock Dividends | |
|---|---|
| Dividend | |
| Dividend Yield | |
| Dividend Growth | |
